The first cholinesterase inhibitor approved by the FDA for treating Alzheimer's, Cognex is rarely prescribed any more, due to its known liver toxicity.

Alzheimer Research Forum Overview of Cognex (tacrine)
Name: Tacrine Other Names: Cognex™ Therapy Types: pharmaceutical Mechanisms: Acetylcholinesterase inhibitor Development Status: approved in U.S. FDA Phase: FDA approved Primary